Yeast as a model organism for studying the actions of DNA topoisomerase-targeted drugs
- 1 October 1998
- journal article
- review article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression
- Vol. 1400 (1-3) , 289-300
- https://doi.org/10.1016/s0167-4781(98)00142-0
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- A Model for the Mechanism of Human Topoisomerase IScience, 1998
- Alterations in the Catalytic Activity of Yeast DNA Topoisomerase I Result in Cell Cycle Arrest and Cell DeathPublished by Elsevier ,1997
- Structure and mechanism of DNA topoisomerase IINature, 1996
- A 26 kDa yeast DNA topoisomerase I fragment: crystallographic structure and mechanistic implicationsStructure, 1995
- Increased Drug Affinity as the Mechanistic Basis for Drug Hypersensitivity of a Mutant Type II TopoisomeraseJournal of Biological Chemistry, 1995
- A Mutation in Yeast TOP2 Homologous to a Quinolone-resistant Mutation in BacteriaJournal of Biological Chemistry, 1995
- A Camptothecin-resistant DNA Topoisomerase I Mutant Exhibits Altered Sensitivities to Other DNA Topoisomerase PoisonsPublished by Elsevier ,1995
- A Yeast Type II Topoisomerase Selected for Resistance to QuinolonesPublished by Elsevier ,1995
- DNA Topoisomerases: Essential Enzymes and Lethal TargetsAnnual Review of Pharmacology and Toxicology, 1994
- A hyper-recombination mutation in S. cerevisiae identifies a novel eukaryotic topoisomeraseCell, 1989